Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > What happens to people who consume hazardous amounts of alcohol?

What happens to people who consume hazardous amounts of alcohol?

Date time 14 November, 2022
News Type News type Research News
Clinical Professor Devanshi Seth, Head of the Centenary Institute’s Alcoholic Liver Disease Laboratory is co-author on a newly published study that has identified factors affecting mortality in people drinking extreme amounts of alcohol.

The study, involving over 6,000 participants from UK Biobank, found that people with chronic excessive alcohol intake died earlier on average, with liver abnormality, alcohol dependence and smoking (which is common among excessive drinkers) all associated with a worse prognosis.

Excessive alcohol intake was defined as 80g of alcohol or more daily for men (approximately eight ordinary beers or eight small glasses of wine) and 50g or more daily for women. Alcohol dependency was defined as drinking at these, or greater levels, 10 years earlier from the point of assessment.

“Mortality risk overall, and from cancers and circulatory diseases, approximately doubled, and increased more than nine fold for liver diseases in participants who reported long-term very high alcohol intake, compared to all other participants,” said Clinical Professor Seth.

“Clinically, excessive drinkers with alcohol dependence and/or alcohol-associated liver damage should be considered for early or intensive management. We may be able to convince at least some of these individuals to reduce their alcohol intake.”

Published in the lead alcohol scientific journal Alcoholism: Clinical and Experimental Research, the lead author of the paper was Dr John Whitfield, QIMR Berghofer Medical Research Institute.

Publication: All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobank.

Themes

  • Inflammation

    Inflammation

Laboratories

  • Seth

People

  • Clinical Professor Devanshi Seth

    Faculty

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • Blood test discovery could help identify head and neck cancer patients at higher risk of relapse

    Researchers at the Centenary Institute, Chris O’Brien Lifehouse, NSW Health Pathology and Royal Prince Alfred Hospital have found a potential new way to help doctors identify which head and neck cancer patients may be at higher risk of their cancer returning, using a simple blood test.
    News Type: Media release
    Date 25 Feb 2026
  • New FAP-Index could transform early detection of severe liver disease

    Researchers from the Centenary Institute have developed a new diagnostic tool, the FAP-Index, that could significantly improve how doctors identify people at risk of serious liver damage caused by metabolic fatty liver disease. The condition affects around one in three Australians with cases projected to increase by 25% to over 7 million by 2030.
    News Type: Media release
    Date 20 Feb 2026
  • First‑of‑its‑kind AI platform to improve cancer treatment decisions

    Centenary researchers have been awarded funding to commercialise a first‑of‑its‑kind medical AI platform designed to improve treatment decisions and reduce unnecessary surgeries for Australian cancer patients. The project, funded through the Australian Government’s Australia’s Economic Accelerator (AEA) Ignite program and led by Dr Yagiz Aksoy, Senior Clinical Research Fellow at Centenary’s Centre for Biomedical AI, ...
    News Type: Research News
    Date 19 Feb 2026
  • New initiative to allow researchers to decode disease like never before

    The Centenary Institute and the University of Sydney have launched a major new initiative that brings next-generation spatial biology technologies together to transform how health threats such as cancer, cardiovascular diseases and infectious diseases are studied and understood.
    News Type: Research News
    Date 11 Feb 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram